Shares of cancer-therapy company Forty Seven Inc. shot up more than 30% in after-hours trading Thursday after a report that Gilead Sciences Inc. has made a takeover offer. Bloomberg News reported that Gilead and Forty Seven, a biotech firm that specializes in cancer immunotherapy, are discussing a number of options, including a partnership, and the company was said to have other suitors as well. Forty Seven's stock is up 192% over the past year, with a market cap of around $2.3 billion. Gilead shares ticked up slightly in extended trading.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Gilead Sciences makes takeover approach to Forty Seven: Bloomberg NewsDrugmaker Gilead Sciences Inc has approached cancer therapy company Forty Seven ...
Les mer »
Seven major Asia-Pacific markets have tumbled into correction territoryA surge in coronavirus cases outside China has sent stock across the world tanking. A number of big Asia markets are in correction territory Friday.
Les mer »
Dentsu's shares slide to seven year lows on Olympics cancellation fearsDentsu Group Inc's shares slid for a sixth day to seven year lows ...
Les mer »
What Glossier’s New Eyeshadow Looks Like on Seven Different Skin TonesWe tried glossier Skywash and had a LOT of thoughts! ✨
Les mer »
Seven Surprising Facts About CoronavirusThe fallout extends far beyond airlines, cruise operators and the stock market.
Les mer »
Seven Surprising Facts About CoronavirusThe economic fallout of the coronavirus outbreak has already been significant, with airlines, cruise operators and manufacturing firms among the hardest hit
Les mer »